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Abstract
Background: Limited information is available regarding the prognostic potential of
muscular fitness parameters in heart failure (HF) with reduced ejection fraction (HFrEF).
Hypothesis: We aimed to investigate the predictive potential of knee extensor mus-
cle strength and power on rehospitalization and evaluate the correlation between
exercise capacity and muscular fitness in patients newly diagnosed with HFrEF.
Methods: Ninety nine patients hospitalized with a new diagnosis of HF were recruited
(64 men; aged 58.7 years [standard deviation (SD), 13.2 years]; 32.3% ischemic; ejection
fraction, 28% [SD, 8%]). The inclusion criteria were left ventricular ejection fraction <40%
and sufficient clinical stability to undergo exercise testing. Aerobic exercise capacity was
measured with cardiopulmonary exercise testing. Knee extensor maximal voluntary iso-
metric contraction (MVIC) and muscle power (MP) were measured using the Baltimore
therapeutic equipment system. The clinical outcome was HF rehospitalization.
Results: Over a mean follow-up period of 1709 ± 502 days, 39 patients were
rehospitalized due to HF exacerbation. HF rehospitalization was more probable for patients
with diabetes and lower oxygen uptake at peak exercise (peak VO2), knee extensor MVIC,
and MP. The Kaplan–Meier survival analysis revealed significantly different cumulative HF
rehospitalization rates according to the tertiles of peak VO2 (P = 0.005) and MP (P = 0.002).
Multivariable Cox proportional hazard model showed that the lowest tertiles of peak VO2
(hazard ratio (HR), 6.26; 95% confidence interval (CI), 1.93–20.27); and MP (HR, 5.29; 95%
CI, 1.05–26.53) were associated with HF rehospitalization. Knee extensor muscle power
was an independent predictor for rehospitalization in patients with HFrEF.
Conclusion: Knee extensor muscle power was an independent predictor for
rehospitalization in patients with HFrEF.
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1 | INTRODUCTION
Heart failure (HF) is a chronic debilitating disease associated with a
50% mortality rate within 5 years of diagnosis.1 Despite advance-
ments in treatment strategies, HF still poses a significant threat to
patient outcomes.2 Patients with HF often complain of fatigue and
shortness of breath even with low-intensity physical activity, which
causes detrimental effects to their quality of life.3,4 Exercise intoler-
ance is a consequence of HF and a major determinant of its progno-
sis.5,6 Measurement of peak oxygen uptake (peak VO2) during
exercise is an objective method for assessing functional capacity and
is an important predictor of long-term prognosis in patients with HF.7
Peak VO2 is used for determining the timing of heart transplantation.
8
The loss of muscle mass and strength occurs progressively with
aging.9 Irrespective of aging, chronic diseases accelerate the atrophy
of muscle fibers or lower the efficiency of energy production in the
muscles, leading to low levels of muscular fitness, which is also associ-
ated with poor prognosis.10,11 In patients with HF, muscular strength
predict long-term survival.6 However, the effect of muscle fitness on
rehospitalization has not been fully investigated. Rehospitalization is
an important outcome for patients with HFrEF, as it relates to quality
of life and high financial burdens for the community.12 Muscular
strength is one of the most common indicators of muscular fitness.
However, muscle performance can also be measured as muscle power
(MP), which indicates the ability of the muscle to perform forceful and
high-velocity movements. Furthermore, as the measurement of MP is
technically simple and relatively easy to assess, it could be incorpo-
rated into a standard prognostic assessment for patients with HFrEF.
Nevertheless, indices of muscular fitness are rarely used in real-world
clinical practice, unlike peak VO2.
Therefore, we aimed to do the following: (a) investigate the pre-
dictive potential of knee extensor muscle strength and power on
rehospitalization; and (b) evaluate the correlation between exercise
capacity and muscular fitness in patients newly diagnosed with
HFrEF.
2 | MATERIAL AND METHODS
2.1 | Study participants
We recruited consecutively a total of 99 patients, who were hospital-
ized with a new diagnosis of HF from January 2013 to November
2015, received subsequent inpatient treatment, and were discharged.
The inclusion criteria were as follows: left ventricular ejection fraction
<40% and sufficient clinical stability to undergo exercise testing.
Patients who underwent surgical procedures such as coronary artery
bypass, valve replacement, heart transplantation, and those on renal
replacement therapy were excluded. Aerobic exercise capacity and
muscular fitness were examined immediately before discharge. We
investigated the medications prescribed at discharge and obtained
blood chemistry data at the time of the 1–2 week follow-up visit. Def-
inition of heart failure rehospitalization was a hospitalization caused
by worsening heart failure symptoms and signs requiring the augmen-
tation of previous medications.13 We identified cases of heart failure
rehospitalization by chart reviewing. All patients provided written
informed consent at enrollment, and the Ethics Committee of Sever-
ance Hospital of the Yonsei University Health System approved the
protocol (No. 4–2018-1180). The study was performed in accordance
with the Declaration of Helsinki.
2.2 | Assessment of aerobic exercise capacity
Functional exercise capacity was evaluated during the maximal tread-
mill exercise test using the Bruce RAMP protocol with the cardiopul-
monary exercise test (CPET) system CASE T2100 (GE Healthcare,
Chicago, IL) under the supervision of a cardiologist. Respiratory gas
exchange analysis was performed throughout the exercise protocol
with a Quark gas analysis system (COSMED, Rome, Italy).
2.3 | Assessment of muscular fitness
The assessments of two muscular fitness parameters were performed
using the Primus RS, version 11 (Baltimore Therapeutic Equipment
Technology, Hanover, MD). For knee extensor muscle strength, the
maximal voluntary isometric contraction (MVIC) and MP were mea-
sured. For measurements of MVIC (Supplemental Video File 1), partic-
ipants were instructed to push with maximum force while keeping the
knee flexed at 45, and the mean value of three measurements was
obtained. To compensate for differences in body weight among par-
ticipants, the value was divided into MVIC per kg of body weight for
use in the statistical analysis. For the assessment of MP
(Supplemental Video File 2), resistance corresponding to 20% of body
weight was applied to compensate for differences in body weight
between the participants, after which, participants were instructed to
flex and extend the knees with maximum effort. The mean value of
the top five results from 10 measurements was used in the statistical
analysis.
2.4 | Statistical analysis
Data were expressed as mean ± standard deviation (SD) frequency
(%), or median (interquartile range [IQR]). Patients were grouped
based on whether they required HF rehospitalization. For group com-
parison of continuous variables, the Student's t-test, one-way analysis
of variance, the Mann–Whitney U test, or the Kruskal-Wallis test was
used. Categorical variables were evaluated using chi-squared test or
Fisher's exact test. Correlation analysis between aerobic exercise
capacity and muscular fitness was performed using Pearson's correla-
tion coefficient. The effect of aerobic exercise capacity or muscular
fitness on HF rehospitalization was analyzed using Kaplan–Meier cur-
ves. Receiver operating characteristic (ROC) analysis was performed
to identify the best cut-off value of peak VO2, MVIC, and MP for HF
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rehospitalization. The association of the tertile of aerobic exercise
capacity or muscular fitness with HF rehospitalization was evaluated
using a multivariable Cox proportional hazard model with adjustment
for age, sex, body mass index, diabetes mellitus, and left ventricular
ejection fraction (LVEF), and N-terminal pro-B-type natriuretic pep-
tide (NT-proBNP). Statistical analyses were conducted using R soft-
ware, version 3.5.3 (R Foundation for Statistical Computing, Vienna,
Austria), assuming a threshold of significance at P < 0.05.
3 | RESULTS
3.1 | Baseline characteristics of patients
Table 1 shows the baseline characteristics of the patients. The mean
age was 58.7 years (SD, 13.2 years), and 64 patients (66.3%) were
male. Their left ventricular (LV) systolic function was markedly
impaired (mean LVEF, 27.5% [SD, 8.1%]). Ischemic cardiomyopathy
accounted for 32.3% of the etiologies of HF.
During the follow-up period (mean: 1691 days [SD, 512 days];
median: 1762 days [IQR, 1588–2059 days]), 39 patients (39.4%) were
rehospitalized due to HF aggravation. Patients with rehospitalization
had lower LVEF and a higher rate of diabetes than those without HF
rehospitalization. Regarding HF guideline-directed medications at
baseline, the use of beta-blockers was significantly lower in patients
with HF rehospitalization than in those without HF rehospitalization.
The use of other medications was not significantly different between
the two groups.
Table 2 shows the results of CPET and muscular fitness tests.
Patients with rehospitalization had significantly lower heart rates at
rest and maximal exercise in CPET. The systolic blood pressure did
not differ between the two groups at rest; however, it was lower dur-
ing maximal exercise in patients with rehospitalization. Moreover, the
exercise time and peak VO2 were significantly lower in patients with
TABLE 1 Baseline characteristics according to rehospitalization in total subjects
Total (N = 99) No rehospitalization (N = 60) Rehospitalization (N = 39) P value
Demographic findings
Age, years 58.3 SD, 13.3 57.3 SD, 12.2 59.9 SD, 15.0 0.351
Men, N(%) 64 (64.6%) 43 (71.7%) 21 (53.8%) 0.110
Height, cm 163.9 ± 8.9 164.6 ± 9.0 162.7 ± 8.6 0.276
Weight, kg 64.4 ± 14.7 65.7 ± 13.0 62.4 ± 16.9 0.274
BMI, kg/m2 23.8 ± 4.1 24.1 ± 3.6 23.4 ± 4.8 0.427
LV ejection fraction, % 27.5 ± 8.1 29.1 ± 8.4 25.1 ± 7.3 0.018
Sinus rhythm, N(%) 73 (73.7%) 44 (73.3%) 29 (74.4%) 0.999
DM, N(%) 25 (27.8%) 9 (17.3%) 16 (42.1%) 0.018
Hypertension, N(%) 39 (43.3%) 21 (40.4%) 18 (47.4%) 0.656
Ischemic cardiomyopathy, N(%) 32 (32.3%) 22 (36.7%) 10 (25.6%) 0.354
Laboratory findings
BUN, mg/dl 18.5 ± 6.6 18.4 ± 5.9 18.8 ± 7.7 0.769
Creatinine, mg/dl 0.9 ± 0.4 1.0 ± 0.2 0.9 ± 0.5 0.390
Serum total protein, d/dl 6.7 ± 0.6 6.8 ± 0.7 6.7 ± 0.6 0.662
Serum albumin, d/dl 4.0 ± 0.5 4.0 ± 0.5 3.9 ± 0.4 0.559
Na+, mmol/L 140.0 ± 2.6 140.4 ± 2.4 139.4 ± 2.9 0.071
K+, mmol/L 4.4 ± 0.5 4.5 ± 0.5 4.3 ± 0.4 0.078
NT-proBNP, pg/ml 1389.5 (718.0–2248.0) 1429.5 (680.0–2263.0) 1342.5 (817.0–1943.5) 0.840
Medications at discharge
ACE inhibitor, N(%) 42 (42.4%) 24 (40.0%) 18 (46.2%) 0.691
ARB, N(%) 36 (36.4%) 23 (38.3%) 13 (33.3%) 0.771
Beta blocker, N(%) 75 (75.8%) 52 (86.7%) 23 (59.0%) 0.004
Ivabradine, N(%) 10 (10.1%) 5 (8.3%) 5 (12.8%) 0.702
Loop diuretics, N(%) 74 (74.7%) 43 (71.7%) 31 (79.5%) 0.523
MRA, N(%) 74 (74.7%) 45 (75.0%) 29 (74.4%) 0.999
Note: Data are presented as mean ± SD, N(%) or median (IQR).
Abbreviations: ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; BMI, body mass index; BUN, blood urea nitrogen; DM, diabetes
mellitus; LV, left ventricular; CMP; MRA, mineralocorticoid antagonist; NT-proBNP. N-terminal pro b-type natriuretic peptide; SD, standard deviation.
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rehospitalization, indicating a clear difference in aerobic exercise
performance between the two groups. The MVIC was significantly
lower in patients with rehospitalization. The MP also tended to
be lower in patients with HF rehospitalization. These results showed
that the patients with HF rehospitalization presented with lower
values for skeletal muscle fitness parameters than those without
rehospitalization.
3.2 | Correlations among parameters of exercise
capacity and muscular fitness
Patients with higher muscular fitness exhibited higher aerobic exercise
capacity (Supplemental Figure 1). MVIC (r = 0.52; 95% confidence
interval (CI), 0.36–0.65; P < 0.001) and MP (r = 0.50; 95% CI, 0.34–
0.63; P < 0.001) showed good correlation with peak VO2 (Figure 1(A),
(B)). In addition, MVIC and MP showed high correlation (r = 0.84; 95%
CI, 0.78–0.89; P < 0.001; Figure 1(C)).
3.3 | Muscular fitness as a predictor for
rehospitalization
Supplemental Table 1 shows the incidence of HF rehospitalization
during the follow-up period according to the peak VO2, MVIC, and
MP tertiles. The incidence of HF rehospitalization was significantly
different according to the peak VO2 tertile. Patients were divided into
three groups (low, middle, and high) according to the tertiles of peak
VO2, MVIC, and MP. Patients with lower aerobic exercise capacity
had more HF rehospitalizations during follow-up (Figure 2). Patients
with lower MVIC tended to present with HF rehospitalization more
frequently; however, the difference was not statistically significant
(Supplemental Table 1), as was the case with the Kaplan–Meier sur-
vival curve (Figure 2). Nevertheless, patients with low MP had signifi-
cantly more HF rehospitalizations than the other groups
(Supplemental Table 1). The Kaplan–Meier curve showed that patients
with low MP were rehospitalized for HF at early periods of follow-up
(Figure 2). ROC curves showed that the best cut-off values of peak
VO2, MVIC, and MP for HF rehospitalization was 20.1 ml/kg, 320 N,
and 87 Watt, respectively (Supplemental Figure 2). The best cut-off
value of peak VO2 was similar to the high tertile value, while the best
cut-off values of MVIC and MP were similar to the low tertile values.
In the multivariable Cox proportional hazard model (Table 3), low
LVEF and DM were important predictors for HF rehospitalization.
Patients with low peak VO2 had a significantly higher risk of HF
rehospitalization than those with high peak VO2 (hazard ratio, 6.26;
95% CI, 1.93–20.27; P = 0.002). Of the indicators for muscular fitness,
only MP showed a significant association with HF rehospitalization.
The patients in the low MP group were 5.29-times more apt to be
rehospitalized for HF than those in the high MP group.
TABLE 2 Parameters of cardiopulmonary exercise test and muscle fitness measurement according to rehospitalization in total subjects
Total No rehospitalization Rehospitalization
P value(N = 99) (N = 60) (N = 39)
Cardiopulmonary exercise test
Heart rate at rest, bpm 84.3 ± 17.6 87.4 ± 18.3 79.5 ± 15.3 0.028
SBP at rest, mmHg 106.8 ± 17.9 108.7 ± 19.6 103.8 ± 14.8 0.187
Peak VO2, ml/kg/min 20.0 ± 5.6 21.6 ± 5.6 17.7 ± 4.6 <0.001
Exercise time, sec 546.3 ± 196.7 604.2 ± 184.8 457.2 ± 182.6 <0.001
AT, ml/kg/min 15.7 ± 5.7 16.4 ± 5.8 14.7 ± 5.6 0.161
RER at peak 1.1 ± 0.1 1.1 ± 0.1 1.1 ± 0.1 0.273
VE/VCO2 slope 36.8 ± 8.2 35.7 ± 7.9 38.4 ± 8.5 0.115
PetCO2, mmHg 33.5 ± 6.7 33.7 ± 5.5 33.2 ± 8.4 0.746
HR at maximal exercise, bpm 137.5 ± 28.3 145.1 ± 30.7 125.9 ± 19.5 <0.001
HR reserve, bpm 53.3 ± 22.8 57.8 ± 24.9 46.4 ± 17.3 0.009
SBP at maximal exercise, mmHg 150.1 ± 30.7 157.4 ± 31.3 139.0 ± 26.3 0.003
SBP reserve, mmHg 43.4 ± 23.6 48.7 ± 24.8 35.2 ± 19.3 0.005
HRR/SBPR 1.6 ± 1.6 1.6 ± 1.8 1.7 ± 1.1 0.651
Muscle fitness measurement
MVIC (N) 373.3 ± 138.6 399.6 ± 131.4 332.9 ± 141.2 0.018
MP (Watt) 134.1 ± 74.3 145.7 ± 67.5 116.2 ± 81.3 0.052
Abbreviations: AT, anaerobic threshold; HR, heart rate; HRR, heart rate reserve; MP, muscle power; MVIC, maximum voluntary isomeric contraction;
PetCO2, pulmonary end-tidal CO2; RER, respiratory exercise ratio; SBP, systolic blood pressure; SBPR, systolic blood pressure reserve; VCO2, carbon
dioxide production; VE, ventilatory equivalents; VO2, oxygen uptake.
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4 | DISCUSSION
In this study, we found that both MP and MVIC were lower in
patients with HF rehospitalization than in those without
rehospitalization. Both these parameters also exhibited a significant
correlation with the peak VO2. However, low MP (and not MVIC) was
significantly associated with the risk of rehospitalization for HF in
patients with HFrEF.
HF rehospitalization incurs high medical costs, putting a great
burden on patients, the health care system, and the social economy.
In addition, it may contribute to the long-term progression of HF and
LV dysfunction.14 In this study, DM and LVEF are the most significant
factors for predicting HF rehospitalization. It is known that HF
patients with DM have a higher risk of HF rehospitalization and a
worse prognosis than those without DM.15 Also, low LVEF is closely
associated with cardiovascular outcomes in HF patients.16 Despite
adjustment of important prognostic factors such as diabetes and
LVEF, our study showed that low aerobic exercise capacity and low
muscular fitness are significant prognostic factors related to HF
rehospitalization.
Peak VO2 is the most objective indicator of physical fitness that
represents the use of oxygen in the cardiac, circulatory, and respira-
tory systems and muscles.17 CPET is recommended in the 2016
European HF Guidelines for identifying the cause of unexplained dys-
pnea or for determining the treatment policies.2 CPET can provide a
more global assessment of patients with HF. CPET parameters are
valid prognostic factors for HF, especially peak VO2 is closely related
to the long-term prognosis of HF.7 In our analysis, among the CPET
parameters, peak VO2 was most closely associated with to HF
rehospitalization (Supplemental Table 2). Our study showed that mus-
cular fitness is also a major predictor of HF prognosis. The isokinetic
strength test of the knee flexor muscle showed that the strength
index was significantly associated with mortality, although peak VO2
was adjusted in multivariable analysis for patients with advanced HF.6
Despite the clear association between muscular fitness and long-term
outcomes of HF, muscular fitness is used less frequently than peak
VO2 for assessing the patients' condition in the clinical settings.
Consistent poor exercise tolerance was observed in the patients
with HF and hypothesized to be due to the pathophysiological
changes in the skeletal muscle.18 Histologic studies on the skeletal
F IGURE 1 Scatterplots and correlation between (A) aerobic exercise capacity and maximal voluntary isometric contraction, (B) aerobic
exercise capacity and muscle power, and (C) maximal voluntary isometric contraction and muscle power. VO2, oxygen uptake
F IGURE 2 Kaplan–Meier curves for heart failure (HF) rehospitalization according to the tertile of (A) aerobic exercise capacity, (B) maximal
voluntary isometric contraction (MVIC), and (C) muscle power (MP). VO2, oxygen uptake
248 LEE ET AL.
muscles in HF identified reduced capillary density and decreased
mitochondrial volume.19,20 Excessive activation of the sympathetic
nervous system and upregulation of the cytokine system induced a
decrease in proteins in the muscle and destruction of those proteins,
thereby reducing muscle mass.21 These muscle-wasting conditions
correlated with maximum peak oxygen uptake in patients with HF.22
In our study, muscular fitness and peak VO2 were significantly corre-
lated, and patients with low MP, probably those with low peak VO2,
had poor prognosis for HF. These findings suggested that the associa-
tion of MP with the prognosis of HF is comparable to that of peak
VO2. In addition, muscular fitness variables in combination with peak
VO2 can more reliably predict hospitalization for heart failure. The
prognostic ability of the combination of peak VO2 and muscular fit-
ness variable was analyzed using the best cut-off values obtained
using ROC analysis. When the peak VO2 was low and the MP or
MVIC was low, the risk of re-hospitalization due to HF was 9–20
times higher than that of the high peak VO2 and high MP or MVIC
(data not shown). However, since the number of subjects is small, fur-
ther research is needed.
As it is generally recommended to measure peak VO2 rather than
muscular fitness in evaluating the physical fitness of patients with HF,
exercise training is primarily focused on aerobic endurance exercise.2
Resistance training is a form of exercise that contracts the muscles
against opposing forces that create resistance, overloading the muscu-
loskeletal system to prevent muscle loss and improve the muscle
strength.23 Although resistance training has survival benefits in
patients with HF, increased afterload during the lifting phase in resis-
tance training may adversely affect the LV function and cause nega-
tive remodeling.24 Therefore, exercise training aimed at improving
muscular fitness in patients with HF has not been widely used. Never-
theless, a position statement of the European Journal of Heart Failure
recommends a patient-specific strength-training program relying on
the accurate and meticulous evaluation of each patient's physical fit-
ness.24 This suggests that there is a need for a reliable method for
evaluating muscular fitness that can be safely practiced in patients.
However, in several studies, methods for measuring muscular fitness
are inconsistent, resulting in a lack of consensus regarding objective
representative indicators of muscular fitness. As patients with chronic
diseases such as HF have lesser muscular fitness than healthy individ-
uals, it may be difficult to apply general methods of measuring muscu-
lar fitness to these patients.
Muscular strength is the force that a muscle or muscle group
exerts against resistance in maximal effort. MVIC is a standardized,
objective, and sensitive tool for measuring muscle strength.25 Power
is defined as the product of force and distance divided by the change
in time. As a measure of muscular fitness, it can be challenging to sep-
arate muscle strength and MP because measuring muscle strength
and power is a dynamic process. In our study, the two indicators were
closely related. However, when comparing the values of the two indi-
cators as functional measures of muscle performance, MP appeared
to be slightly better. In adults aged ≥65 years, decreased MP affects
physical performance three times more than decreased muscle
strength.26 MP decreases with age, possibly occurring earlier than
changes in peak muscle strength; this has drawn attention as an
essential predictor of reduced activity in older patients.27
Only a few studies have measured MP and strength separately in
patients with HF; to the best of our knowledge, this is the first study
to analyze the long-term prognostic relationship of these two indica-
tors with HF. We demonstrated that MP was a better indicator of
muscular fitness for predicting the long-term prognosis of HF than
MVIC, an indicator of muscle strength. The measurement of MVIC
may cause the Valsalva maneuver, which may induce stress in the left
ventricle.24 As the MP measurement method used in our study is per-
formed according to the individual weight load, it is possible to mea-
sure muscular fitness more safely. Therefore, measuring MP as an
indicator of prognosis in patients with HF and for guiding muscle
training to reduce muscle loss may be useful for facilitating a multi-
disciplinary approach towards HF.
This study has several limitations. First, our subjects were those
who had physical activity sufficient to measure both CPET and
TABLE 3 Multivariable Cox proportional hazard regression analyses for HF rehospitalization according to the tertiles of aerobic exercise
capacity and muscle fitness
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
Age 1.00 (0.97–1.02) 0.733 Age 0.99 (0.97–1.02) 0.692 Age 0.99 (0.95–1.03) 0.540
Female 1.18 (0.54–2.55) 0.681 Female 1.31 (0.54–3.22) 0.551 Female 0.97 (0.36–2.60) 0.945
BMI 1.01 (0.91–1.11) 0.897 BMI 1.01 (0.90–1.13) 0.869 BMI 1.04 (0.84–1.15) 0.431
DM 2.96 (1.50–5.85) 0.002 DM 3.54 (1.69–7.42) <0.001 DM 2.64 (1.34–5.21) 0.005
LVEF 0.93 (0.88–0.97) 0.001 LVEF 0.92 (0.88–0.97) 0.001 LVEF 0.93 (0.69–0.97) 0.002
NT-proBNP 1.00 (1.00–1.00) 0.837 NT-proBNP 1.00 (1.00–1.00) 0.831 NT-proBNP 1.00 (1.00–1.00) 0.804
Peak VO2 tertile MVIC tertile MP tertile
High Reference - High Reference - High Reference -
Middle 2.85 (0.98–8.31) 0.054 Middle 1.19 (0.40–3.52) 0.752 Middle 1.32 (0.37–4.77) 0.668
Low 6.26 (1.93–20.27) 0.002 Low 3.11 (0.80–12.20) 0.102 Low 5.29 (1.05–26.53) 0.043
Abbreviations: BMI, body mass index; CI, confidence interval; DM, diabetes mellitus; HF, heart failure; HR, hazard ratio; LVEF, left ventricular ejection
fraction; MP, muscle power; MVIC, maximum voluntary isomeric contraction; NT-proBNP. N-terminal pro b-type natriuretic peptide; VO2, oxygen uptake.
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muscular fitness. Therefore, there was a high possibility that patients
with severe muscle loss were not included, and it might be difficult to
generalize the results of this study to all patients with severe
advanced HF. Nevertheless, measuring MP will not be difficult in
patients with disability because its feasibility has been demonstrated
in older populations with sarcopenia. Second, we did not demonstrate
that MP was related to the prognosis of HF independently of peak
VO2. This is because peak VO2 and MP were highly correlated and
subjects with low peak VO2 or low muscular fitness shared clinical
features such as old age, female, and high NT-proBNP levels
(Supplemental Table 3–7). However, the fact that MP was signifi-
cantly associated with the prognosis of HF as much as peak VO2 sug-
gests that measuring MP in patients is an alternative to measuring
physical fitness. Third, the medications used after discharge were not
reflected in the research results. In addition, lower prescription of
beta-blockers at discharge in patients with low MP may have had an
impact on long-term prognosis. Fourth, the number of subjects who
participated in the study was relatively small.
In conclusion, aerobic exercise capacity and muscle fitness were
associated with the prognosis of patients with HFrEF. Compared with
MVIC, which is the traditional method of measuring knee extensor fit-
ness, measurement of MP was found to be a better predictor for HF
rehospitalization in these patients.
ACKNOWLEDGMENTS
We would like to thank Editage (www.editage.co.kr) for English lan-
guage editing.
CONFLICT OF INTEREST
The authors declare that they have no competing interests.
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the
corresponding author upon reasonable request.
ORCID




1. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence
of and survival with heart failure. N Engl J Med. 2002;347:1397-1402.
2. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the
diagnosis and treatment of acute and chronic heart failure: the task
force for the diagnosis and treatment of acute and chronic heart fail-
ure of the European Society of Cardiology (ESC)developed with the
special contribution of the heart failure association (HFA) of the ESC.
Eur Heart J. 2016;37:2129-2200.
3. Pina IL, Apstein CS, Balady GJ, et al. Exercise and heart failure: a
statement from the American Heart Association Committee on exer-
cise, rehabilitation. And Prevention Circulation. 2003;107:1210-1225.
4. Taylor RS, Walker S, Smart NA, et al. Impact of exercise rehabilitation
on exercise capacity and quality-of-life in heart failure: individual par-
ticipant meta-analysis. J Am Coll Cardiol. 2019;73:1430-1443.
5. Myers J, Gullestad L, Vagelos R, et al. Clinical, hemodynamic, and cardio-
pulmonary exercise test determinants of survival in patients referred for
evaluation of heart failure. Ann Intern Med. 1998;129:286-293.
6. Hulsmann M, Quittan M, Berger R, et al. Muscle strength as a predic-
tor of long-term survival in severe congestive heart failure. Eur J Heart
Fail. 2004;6:101-107.
7. Malhotra R, Bakken K, D'Elia E, et al. Cardiopulmonary exercise test-
ing in heart failure. JACC Heart Fail. 2016;4:607-616.
8. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr,
Wilson JR. Value of peak exercise oxygen consumption for optimal
timing of cardiac transplantation in ambulatory patients with heart
failure. Circulation. 1991;83:778-786.
9. Goldspink G. Age-related loss of muscle mass and strength. J Aging
Res. 2012;2012:158279.
10. Ebner N, Sliziuk V, Scherbakov N, Sandek A. Muscle wasting in ageing
and chronic illness. ESC Heart Fail. 2015;2:58-68.
11. Artero EG, Lee DC, Lavie CJ, et al. Effects of muscular strength on
cardiovascular risk factors and prognosis. J Cardiopulm Rehabil Prev.
2012;32:351-358.
12. Jackson SL, Tong X, King RJ, Loustalot F, Hong Y, Ritchey MD.
National burden of heart failure events in the united states, 2006 to
2014. Circ Heart Fail. 2018;11(12):e004873. http://dx.doi.org/10.
1161/circheartfailure.117.004873.
13. Zannad F, Garcia AA, Anker SD, et al. Clinical outcome endpoints in heart
failure trials: a European Society of Cardiology Heart Failure Association
consensus document. Eur J Heart Fail. 2013;15:1082-1094.
14. Gheorghiade M, De Luca L, Fonarow GC, et al. Pathophysiologic tar-
gets in the early phase of acute heart failure syndromes. Am J Cardiol.
2005;96:11g-17g.
15. Pocock SJ, Ariti CA, McMurray JJ, et al. Predicting survival in heart
failure: a risk score based on 39 372 patients from 30 studies. Eur
Heart J. 2013;34:1404-1413.
16. Solomon SD, Anavekar N, Skali H, et al. Influence of ejection fraction
on cardiovascular outcomes in a broad spectrum of heart failure
patients. Circulation. 2005;112:3738-3744.
17. Guazzi M, Adams V, Conraads V, et al. EACPR/AHA scientific state-
ment. Clinical recommendations for cardiopulmonary exercise testing
data assessment in specific patient populations. Circulation. 2012;
126:2261-2274.
18. Stewart Coats AJ. From the muscle hypothesis to a muscle solution?
ESC Heart Fail. 2019;6:239-240.
19. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and
histology in ambulatory patients with long-term heart failure. Circula-
tion. 1990;81:518-527.
20. Massie BM, Conway M, Yonge R, et al. 31P nuclear magnetic reso-
nance evidence of abnormal skeletal muscle metabolism in patients
with congestive heart failure. Am J Cardiol. 1987;60:309-315.
21. Anker SD, Ponikowski PP, Clark AL, et al. Cytokines and neurohor-
mones relating to body composition alterations in the wasting syn-
drome of chronic heart failure. Eur Heart J. 1999;20:683-693.
22. Fulster S, Tacke M, Sandek A, et al. Muscle wasting in patients with
chronic heart failure: results from the studies investigating co-
morbidities aggravating heart failure (SICA-HF). Eur Heart J. 2013;34:
512-519.
23. Williams MA, Haskell WL, Ades PA, et al. Resistance exercise in indi-
viduals with and without cardiovascular disease: 2007 update: a sci-
entific statement from the American Heart Association Council on
clinical cardiology and council on nutrition, physical activity, and
metabolism. Circulation. 2007;116:572-584.
24. Piepoli MF, Conraads V, Corra U, et al. Exercise training in heart failure:
from theory to practice. A consensus document of the heart failure asso-
ciation and the European Association for Cardiovascular Prevention and
Rehabilitation. Eur J Heart Fail. 2011;13:347-357.
25. Meldrum D, Cahalane E, Keogan F, Hardiman O. Maximum
voluntary isometric contraction: investigation of reliability and
250 LEE ET AL.
learning effect. Amyotroph Lateral Scler Other Motor Neuron Disord.
2003;4:36-44.
26. Bean JF, Leveille SG, Kiely DK, et al. A comparison of leg
power and leg strength within the InCHIANTI study: which
influences mobility more? J Gerontol A Biol Sci Med Sci. 2003;58:
728-733.
27. Reid KF, Pasha E, Doros G, et al. Longitudinal decline of lower
extremity muscle power in healthy and mobility-limited older
adults: influence of muscle mass, strength, composition, neuro-
muscular activation and single fiber contractile properties. Eur J
Appl Physiol. 2014;114(1):29-39. http://dx.doi.org/10.1007/s00421-
013-2728-2.
SUPPORTING INFORMATION
Additional supporting information may be found online in the
Supporting Information section at the end of this article.
How to cite this article: Lee CJ, Ryu HY, Chun K-H, et al.
Association of muscular fitness with rehospitalization for heart
failure with reduced ejection fraction. Clin Cardiol. 2021;44:
244–251. https://doi.org/10.1002/clc.23535
LEE ET AL. 251
